Delivery Order SPE2DB20D7059-SPE2DB25FGQU9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Ketorolac 15 mg/ml vials at a firm fixed price ceiling value of $1,476.08. This is an unset-aside, competitively awarded delivery order with an ultimate completion date of September 9, 2025. The product will be supplied from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ketorolac 10 mg tablets (100-count) with a firm fixed price ceiling value of $1,003.92. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of June 26, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work from its corporate office location. This delivery order represents a single...
- The Defense Logistics Agency awarded a $1,939.60 delivery order to AmerisourceBergen Drug Corp for the supply of Ketorolac 30 mg/ml vials. This firm fixed-price contract, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Ketorolac 30 mg/ml vials under a firm fixed-price contract with a ceiling value of $2,695.94. This is a non-set-aside competitive award with an ultimate completion date of September 10, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $1,194.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Ketorolac 30 mg/ml vials. The contract is a non-set-aside competitive award with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of August 19, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency has awarded a delivery order valued at $2,909.40 to AmerisourceBergen Drug Corp for the supply of Ketorolac 30 mg/mL vials. This competitive award, issued on August 19, 2025, represents a firm fixed price delivery order with an ultimate completion date of August 20, 2025. The pharmaceutical distributor will fulfill this order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,427.96 to AmerisourceBergen Drug Corp for the supply of Ketorolac 30 mg/mL vials. This contract, awarded on August 28, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 29, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, indicating it was competitively procured through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ketorolac 30 mg/mL vials with a ceiling value of $1,939.60. This non-set-aside contract was awarded on August 12, 2025, with an ultimate completion date of August 13, 2025, and is structured as a firm fixed-price delivery order. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Ketorolac 30 mg/mL vials valued at $1,298.52. This award represents a firm fixed-price delivery order with no set-aside designation, indicating competitive selection among qualified vendors. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. As a child...
- The Defense Logistics Agency awarded a $1,086.88 delivery order to AmerisourceBergen Drug Corp for Ketorolac 30 mg/ml vials under a firm fixed price contract type. The award was issued on July 11, 2025, with an ultimate completion date of July 14, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order is a child contract under...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FGQU9Delivery Order
The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Ketorolac 10 mg tablets (100-count units) with a ceiling value of $1,985.20. The contract is a non-set-aside award performed at AmerisourceBergen's Conshohocken, Pennsylvania location, with an ultimate completion date of September 4, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply medications, vaccines, and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated significant capability in federal medical procurement through its competitive contract awards with the Defense Logistics Agency. The company serves critical defense and veteran healthcare needs by supplying a comprehensive range of brand-name and generic medications, including pain management pharmaceuticals, specialty drugs, and related medical commodities. This delivery order for Ketorolac, a nonsteroidal anti-inflammatory drug commonly used for pain management in military medical settings, represents a routine fulfillment under the company's established prime vendor relationship with DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 9/3/25 |